Clinical events more than 2 years after HSCT
| Clinical events . | No. of patients (%) . |
|---|---|
| Overall | 43 (48) |
| Persistent cGVHD | 10 (11) |
| Autoimmune/inflammatory events | 12 (13) |
| AIHA | 6 |
| Myositis | 2 |
| Psoriasis, vitiligo, alopecia | 1 |
| Ill-defined inflammatory disease | 3 |
| Disseminated granulomatous disease | 1 |
| Severe or recurrent infection | 11 (12) |
| Opportunistic infection | 3 |
| Recurrent LRTI | 2 |
| Chronic sinusitis and/or chronic bronchopneumopathy | 6 |
| Viral encephalitis | 1 |
| Chronic HPV infection | 23 (25) |
| Severe HPV infection | 9 |
| Mild HPV infection | 14 |
| Nutritional support | 18 (20) |
| Enteral feeding | 11 |
| Parenteral nutrition | 7 |
| Boost | 11 (12) |
| Growth insufficiency (weight and/or height less than the third percentile) | 16 (18) |
| Obesity | 3 (3) |
| Psychosocial disabilities | 6 (7) |
| Myelodysplasia* | 2 (2) |
| Late-onset mortality | 8 (9) |
| Clinical events . | No. of patients (%) . |
|---|---|
| Overall | 43 (48) |
| Persistent cGVHD | 10 (11) |
| Autoimmune/inflammatory events | 12 (13) |
| AIHA | 6 |
| Myositis | 2 |
| Psoriasis, vitiligo, alopecia | 1 |
| Ill-defined inflammatory disease | 3 |
| Disseminated granulomatous disease | 1 |
| Severe or recurrent infection | 11 (12) |
| Opportunistic infection | 3 |
| Recurrent LRTI | 2 |
| Chronic sinusitis and/or chronic bronchopneumopathy | 6 |
| Viral encephalitis | 1 |
| Chronic HPV infection | 23 (25) |
| Severe HPV infection | 9 |
| Mild HPV infection | 14 |
| Nutritional support | 18 (20) |
| Enteral feeding | 11 |
| Parenteral nutrition | 7 |
| Boost | 11 (12) |
| Growth insufficiency (weight and/or height less than the third percentile) | 16 (18) |
| Obesity | 3 (3) |
| Psychosocial disabilities | 6 (7) |
| Myelodysplasia* | 2 (2) |
| Late-onset mortality | 8 (9) |
AIHA indicates autoimmune hemolytic anaemia; and LRTI, lower respiratory tract infection.
Patients with reticular dysgenesis.